Liquid Biopsy Market to Witness Huge Growth by 2031| Key Players - Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Exosome Sciences Inc., Grail Inc

DataM Intelligence has released a new research report on the Liquid Biopsy market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like benefits, gross margins, and strategic decisions in the global market. The report is enriched with tables, charts, and infographics for a clear presentation of the findings.

The Global Liquid Biopsy Market reached USD 4.1 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 12.3 billion by 2031. The Global Liquid Biopsy Market is expected to exhibit a CAGR of 15.4% during the forecast period 2024-2031

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/liquid-biopsy-market

A liquid biopsy is a minimally invasive diagnostic test that analyzes biomarkers in bodily fluids, primarily blood, to detect and monitor diseases, particularly cancer. Unlike traditional biopsies, which involve extracting tissue samples, liquid biopsies analyze circulating tumor cells (CTCs), cell-free DNA (cfDNA), or exosomes released by tumors into the bloodstream. This approach allows for real-time monitoring of tumor dynamics, genetic mutations, and treatment response, enabling personalized medicine and improving patient management. Liquid biopsies offer advantages such as reduced risk, quicker recovery, and the ability to assess the heterogeneity of tumors.

List of the Key Players in the Liquid Biopsy Market:

Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Exosome Sciences Inc., Grail Inc, Guardant Health, Thermo Fisher Scientific Inc., Inivata Ltd, Illumina Inc, LungLife AI Inc, and Qiagen NV among others.

Key Developments:

On April 18, 2023, Qiagen, a leading provider of sample and assay technologies for molecular diagnostics, announced the launch of its QIAseq Targeted cfDNA Ultra Panels. These panels will enable researchers investigating cancer and other diseases to rapidly convert cell-free DNA (cfDNA) liquid biopsy samples into libraries prepared for next-generation sequencing (NGS) in under eight hours.

On the same day, Stilla Technologies unveiled 20 new digital PCR assays optimized for its Crystal Digital PCR platform, known as the Naica system. These assays are designed for detecting circulating tumor DNA (ctDNA) from liquid biopsy samples. Produced in collaboration with distributor and technology partner ApexBio, these digital PCR kits facilitate the absolute quantification of nucleic acids associated with various genetic mutations across a broad spectrum of oncological indications.

Additionally, on November 30, 2022, Thermo Fisher Scientific launched a range of dPCR Liquid Biopsy assays for their Applied Biosystems Absolute Q dPCR system and introduced a custom design tool aimed at enhancing cancer research efforts.

Research Process:

Both primary and secondary data sources have been used in the global Liquid Biopsy Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the Liquid Biopsy Market:

By Circulating Biomarker: Circulating Tumor Cells, Circulating Tumor DNA, Extracellular Vesicles and Others

By Product & Services: Kits & Reagents, Instruments, Services

By Applications: Cancer Applications (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Liver Cancer, Other Cancers), Non-Cancer Applications

By End User: Hospitals and Physician Laboratories, Research Centers and Others

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/liquid-biopsy-market

Regional Analysis:

➣ North America (US, Canada, Mexico)

➣ Europe (Germany, Russia, UK, France, Italy, Spain, Rest of Europe)

➣ Asia-Pacific (China, India, Japan, Australia, Rest of Asia Pacific)

➣ South America (Brazil, Argentina, Rest of South America)

➣ Middle East and Africa

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Liquid Biopsy market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Liquid Biopsy Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Liquid Biopsy market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Liquid Biopsy Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/liquid-biopsy-market

The Research Report Offers Answers To The Following Questions:

☛ What is the expected growth rate of the global market for the forecast period?

☛ What are the key driving factors that are responsible to shape the fate of the Liquid Biopsy market during the forecast period?

☛ What will be the overall size of the market during the analysis period?

☛ What are the prominent market trends which influence the development of the Liquid Biopsy market across various regions?

☛ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?

☛ What are the challenges and threats that are likely to act as a barrier to the growth of the Liquid Biopsy market?

☛ What are the major opportunities that the companies can get to attain success in the world?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.